UNSPSC 51331704: Sultopride
Commodity
Code facts
- Part of
-
-
51000000
-
51330000
- 51331700
-
51330000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51331704
Definition
This classification denotes an antipsychotic agent with the molecular formula C17H26N2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AA0G3TW31W, chemically known as o-anisamide, n-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)- but generally known as sultopride, which bears US NIH Compound Identifier 5357. European Medicines Agency schedules Sultopride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10763MIG.
Read the full definition
The term SULTOPRIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). World Health Organization schedules sultopride in its Anatomical Therapeutic Chemical (ATC) Classification. SULTOPRIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule sultopride under HS 29339990 and SITC 51577. As of Q4 2014, SULTOPRIDE remains the US FDA Preferred Term for this commodity. Sultopride bears US NLM identifiers UMLS ID C0075630 and NCI Concept Code C73291.
SMILES: S(=O)(=O)(C1CC(C(=O)NCC2N(CCC2)CC)C(OC)CC1)CC.
About UNSPSC 51331704
UNSPSC 51331704 Sultopride is a Commodity code that does not appear in the recent state and local procurement record. The three most recent opportunities posted under this code involve naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and OTC products—none of which are sultopride or closely related pharmaceutical products. The source shows a mismatch between the code's nominal scope and the work actually being solicited, indicating that this Commodity code sees little relevant recent activity in state and local procurement.
The sole opportunity directly aligned with the code's scope is Seminole County, Florida's IFB60459723LAS, posted June 30, 2026, to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bid with a July 26, 2023 response deadline. The Texas Health and Human Services Commission issued RFI HHS0017013 in April 2026 to gather vendor information on direct-to-manufacturer prescription programs, while the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) released an RFP (S1070000015802) in January 2026 for generic pharmaceuticals and OTC products to be awarded by May 15, 2026 and effective July 1, 2026. County health and human services agencies, state health departments, and cooperative purchasing alliances represent the issuing-body mix for pharmaceutical and health-product procurement at this level. Activity concentrates in Florida, Texas, and Minnesota based on the recent record.
Quick answers
What is UNSPSC 51331704?
UNSPSC 51331704 is Sultopride, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51331704?
UNSPSC 51331704 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).
On GovTribe
See everything under UNSPSC 51331704
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code